scPharmaceuticals Inc (SCPH)
3.35
-0.11
(-3.18%)
USD |
NASDAQ |
Nov 22, 16:00
3.355
0.00 (0.00%)
Pre-Market: 20:00
scPharmaceuticals Total Liabilities (Quarterly): 94.36M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 94.36M |
| June 30, 2024 | 56.21M |
| March 31, 2024 | 53.89M |
| December 31, 2023 | 57.26M |
| September 30, 2023 | 56.96M |
| June 30, 2023 | 50.74M |
| March 31, 2023 | 51.56M |
| December 31, 2022 | 51.76M |
| September 30, 2022 | 17.29M |
| June 30, 2022 | 18.70M |
| March 31, 2022 | 19.50M |
| December 31, 2021 | 22.57M |
| September 30, 2021 | 24.42M |
| June 30, 2021 | 24.57M |
| March 31, 2021 | 24.78M |
| Date | Value |
|---|---|
| December 31, 2020 | 26.88M |
| September 30, 2020 | 27.14M |
| June 30, 2020 | 25.86M |
| March 31, 2020 | 25.38M |
| December 31, 2019 | 25.92M |
| September 30, 2019 | 28.78M |
| June 30, 2019 | 19.99M |
| March 31, 2019 | 17.19M |
| December 31, 2018 | 15.01M |
| September 30, 2018 | 15.43M |
| June 30, 2018 | 16.42M |
| March 31, 2018 | 15.71M |
| December 31, 2017 | 16.05M |
| September 30, 2017 | 14.28M |
| December 31, 2016 | 76.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
17.29M
Minimum
Sep 2022
94.36M
Maximum
Sep 2024
37.79M
Average
26.40M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.07M |
| Shareholders Equity (Quarterly) | 30.71M |
| Debt to Equity Ratio | 1.664 |
| Current Ratio | 8.080 |
| Net Debt Paydown Yield | -1.17% |